Titre : Benzoate de sodium

Benzoate de sodium : Questions médicales fréquentes

Termes MeSH sélectionnés :

Double-Blind Method
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Benzoate de sodium : Questions médicales les plus fréquentes", "headline": "Benzoate de sodium : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Benzoate de sodium : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-08", "dateModified": "2025-03-05", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Benzoate de sodium" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Acide benzoïque", "url": "https://questionsmedicales.fr/mesh/D019817", "about": { "@type": "MedicalCondition", "name": "Acide benzoïque", "code": { "@type": "MedicalCode", "code": "D019817", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.127.117" } } }, "about": { "@type": "MedicalCondition", "name": "Benzoate de sodium", "alternateName": "Sodium Benzoate", "code": { "@type": "MedicalCode", "code": "D020160", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Chieh-Hsin Lin", "url": "https://questionsmedicales.fr/author/Chieh-Hsin%20Lin", "affiliation": { "@type": "Organization", "name": "Department of Psychiatry, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Kaohsiung, Taiwan." } }, { "@type": "Person", "name": "Hsien-Yuan Lane", "url": "https://questionsmedicales.fr/author/Hsien-Yuan%20Lane", "affiliation": { "@type": "Organization", "name": "Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan." } }, { "@type": "Person", "name": "Andrea Baker", "url": "https://questionsmedicales.fr/author/Andrea%20Baker", "affiliation": { "@type": "Organization", "name": "Queensland Centre for Mental Health Research, The Park Centre for Mental Health, Wacol, Australia." } }, { "@type": "Person", "name": "Anne Gordon", "url": "https://questionsmedicales.fr/author/Anne%20Gordon", "affiliation": { "@type": "Organization", "name": "Metro North Mental Health, Royal Brisbane and Women's Hospital, Herston, Australia." } }, { "@type": "Person", "name": "George Bruxner", "url": "https://questionsmedicales.fr/author/George%20Bruxner", "affiliation": { "@type": "Organization", "name": "Metro North Mental Health, Caboolture and Redcliffe Hospitals, Caboolture, Australia." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol.", "datePublished": "2022-12-20", "url": "https://questionsmedicales.fr/article/36600424", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2022-067251" } }, { "@type": "ScholarlyArticle", "name": "Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.", "datePublished": "2022-05-23", "url": "https://questionsmedicales.fr/article/35617986", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/S2213-2600(22)00088-1" } }, { "@type": "ScholarlyArticle", "name": "Comparison Between Esketamine and Alfentanil for Hysteroscopy: A Prospective, Double-Blind, Randomized Controlled Trial.", "datePublished": "2024-08-14", "url": "https://questionsmedicales.fr/article/39161682", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2147/DDDT.S472651" } }, { "@type": "ScholarlyArticle", "name": "Efficacy of Liposomal Melatonin in sleep EEG in Childhood: A Double Blind Case Control Study.", "datePublished": "2022-12-29", "url": "https://questionsmedicales.fr/article/36612875", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/ijerph20010552" } }, { "@type": "ScholarlyArticle", "name": "Licogliflozin for nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled, phase 2a study.", "datePublished": "2022-06-20", "url": "https://questionsmedicales.fr/article/35725922", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41591-022-01861-9" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Hydrocarbures", "item": "https://questionsmedicales.fr/mesh/D006838" }, { "@type": "ListItem", "position": 4, "name": "Hydrocarbures cycliques", "item": "https://questionsmedicales.fr/mesh/D006844" }, { "@type": "ListItem", "position": 5, "name": "Hydrocarbures aromatiques", "item": "https://questionsmedicales.fr/mesh/D006841" }, { "@type": "ListItem", "position": 6, "name": "Dérivés du benzène", "item": "https://questionsmedicales.fr/mesh/D001555" }, { "@type": "ListItem", "position": 7, "name": "Benzoates", "item": "https://questionsmedicales.fr/mesh/D001565" }, { "@type": "ListItem", "position": 8, "name": "Acide benzoïque", "item": "https://questionsmedicales.fr/mesh/D019817" }, { "@type": "ListItem", "position": 9, "name": "Benzoate de sodium", "item": "https://questionsmedicales.fr/mesh/D020160" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Benzoate de sodium - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Benzoate de sodium", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-14", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Benzoate de sodium", "description": "Comment diagnostiquer une allergie au benzoate de sodium ?\nQuels tests sont utilisés pour évaluer l'exposition au benzoate ?\nQuels symptômes indiquent une intoxication au benzoate ?\nComment évaluer une réaction cutanée au benzoate ?\nLe benzoate de sodium peut-il être détecté dans les tests de toxicologie ?", "url": "https://questionsmedicales.fr/mesh/D020160?mesh_terms=Double-Blind+Method&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Benzoate de sodium", "description": "Quels sont les symptômes d'une hypersensibilité au benzoate ?\nLe benzoate de sodium cause-t-il des effets secondaires ?\nComment se manifeste une réaction allergique au benzoate ?\nLe benzoate de sodium peut-il provoquer des troubles digestifs ?\nQuels symptômes neurologiques peuvent être liés au benzoate ?", "url": "https://questionsmedicales.fr/mesh/D020160?mesh_terms=Double-Blind+Method&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Benzoate de sodium", "description": "Comment éviter les allergies au benzoate de sodium ?\nQuelles alternatives au benzoate de sodium existent ?\nLes enfants doivent-ils éviter le benzoate ?\nComment sensibiliser sur les dangers du benzoate ?\nLe benzoate de sodium est-il sûr dans les aliments ?", "url": "https://questionsmedicales.fr/mesh/D020160?mesh_terms=Double-Blind+Method&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Benzoate de sodium", "description": "Quel traitement pour une réaction allergique au benzoate ?\nComment traiter une intoxication au benzoate de sodium ?\nY a-t-il des antidotes pour le benzoate de sodium ?\nComment gérer les effets secondaires du benzoate ?\nLe benzoate de sodium nécessite-t-il un suivi médical ?", "url": "https://questionsmedicales.fr/mesh/D020160?mesh_terms=Double-Blind+Method&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Benzoate de sodium", "description": "Quelles complications peuvent survenir avec une allergie au benzoate ?\nLe benzoate de sodium peut-il affecter le foie ?\nY a-t-il des risques de cancer liés au benzoate ?\nLe benzoate de sodium peut-il affecter le système nerveux ?\nQuelles sont les conséquences d'une surconsommation ?", "url": "https://questionsmedicales.fr/mesh/D020160?mesh_terms=Double-Blind+Method&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Benzoate de sodium", "description": "Qui est le plus à risque d'allergie au benzoate ?\nLes personnes asthmatiques sont-elles à risque ?\nLe risque d'allergie augmente-t-il avec l'âge ?\nLes personnes ayant des maladies chroniques sont-elles à risque ?\nLe mode de vie influence-t-il le risque d'allergie ?", "url": "https://questionsmedicales.fr/mesh/D020160?mesh_terms=Double-Blind+Method&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une allergie au benzoate de sodium ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par des tests cutanés ou des tests sanguins pour détecter des anticorps." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'exposition au benzoate ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de laboratoire peuvent mesurer les niveaux de benzoate dans le sang ou l'urine." } }, { "@type": "Question", "name": "Quels symptômes indiquent une intoxication au benzoate ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des nausées, des vomissements et des douleurs abdominales." } }, { "@type": "Question", "name": "Comment évaluer une réaction cutanée au benzoate ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Une évaluation clinique et un historique médical détaillé sont nécessaires." } }, { "@type": "Question", "name": "Le benzoate de sodium peut-il être détecté dans les tests de toxicologie ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut être détecté dans des tests spécifiques de toxicologie alimentaire." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une hypersensibilité au benzoate ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des démangeaisons, des éruptions cutanées et des maux de tête." } }, { "@type": "Question", "name": "Le benzoate de sodium cause-t-il des effets secondaires ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des effets secondaires comme des nausées et des vertiges peuvent survenir." } }, { "@type": "Question", "name": "Comment se manifeste une réaction allergique au benzoate ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut se manifester par des urticaires, des gonflements et des difficultés respiratoires." } }, { "@type": "Question", "name": "Le benzoate de sodium peut-il provoquer des troubles digestifs ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, il peut entraîner des troubles digestifs comme des douleurs abdominales et des diarrhées." } }, { "@type": "Question", "name": "Quels symptômes neurologiques peuvent être liés au benzoate ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des maux de tête et des vertiges peuvent être observés." } }, { "@type": "Question", "name": "Comment éviter les allergies au benzoate de sodium ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les aliments contenant du benzoate et lisez attentivement les étiquettes." } }, { "@type": "Question", "name": "Quelles alternatives au benzoate de sodium existent ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Des conservateurs naturels comme l'acide citrique ou le vinaigre peuvent être utilisés." } }, { "@type": "Question", "name": "Les enfants doivent-ils éviter le benzoate ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants sensibles devraient éviter le benzoate en raison de risques d'hyperactivité." } }, { "@type": "Question", "name": "Comment sensibiliser sur les dangers du benzoate ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Des campagnes d'information et des étiquettes claires peuvent aider à sensibiliser." } }, { "@type": "Question", "name": "Le benzoate de sodium est-il sûr dans les aliments ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Il est généralement considéré comme sûr en quantités réglementées, mais des précautions s'imposent." } }, { "@type": "Question", "name": "Quel traitement pour une réaction allergique au benzoate ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les antihistaminiques et les corticostéroïdes peuvent être prescrits pour soulager les symptômes." } }, { "@type": "Question", "name": "Comment traiter une intoxication au benzoate de sodium ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement inclut l'élimination de l'exposition et des soins symptomatiques." } }, { "@type": "Question", "name": "Y a-t-il des antidotes pour le benzoate de sodium ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique." } }, { "@type": "Question", "name": "Comment gérer les effets secondaires du benzoate ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Il est conseillé de réduire l'exposition et de consulter un médecin pour des conseils." } }, { "@type": "Question", "name": "Le benzoate de sodium nécessite-t-il un suivi médical ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Un suivi médical est recommandé en cas de réactions sévères ou d'allergies confirmées." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec une allergie au benzoate ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications graves comme un choc anaphylactique peuvent survenir dans des cas extrêmes." } }, { "@type": "Question", "name": "Le benzoate de sodium peut-il affecter le foie ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition excessive peut entraîner des troubles hépatiques, bien que rare." } }, { "@type": "Question", "name": "Y a-t-il des risques de cancer liés au benzoate ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des études suggèrent un lien potentiel avec certains cancers, mais les preuves sont limitées." } }, { "@type": "Question", "name": "Le benzoate de sodium peut-il affecter le système nerveux ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une exposition excessive peut entraîner des effets neurologiques, comme des maux de tête." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une surconsommation ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une surconsommation peut entraîner des troubles digestifs et des réactions allergiques." } }, { "@type": "Question", "name": "Qui est le plus à risque d'allergie au benzoate ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les personnes ayant des antécédents d'allergies alimentaires sont plus à risque." } }, { "@type": "Question", "name": "Les personnes asthmatiques sont-elles à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes asthmatiques peuvent être plus sensibles aux effets du benzoate." } }, { "@type": "Question", "name": "Le risque d'allergie augmente-t-il avec l'âge ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Le risque d'allergie peut augmenter chez les enfants, mais il varie selon les individus." } }, { "@type": "Question", "name": "Les personnes ayant des maladies chroniques sont-elles à risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes atteintes de maladies chroniques peuvent avoir une sensibilité accrue." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque d'allergie ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain peut réduire le risque d'allergies alimentaires, y compris au benzoate." } } ] } ] }

Sources (10000 au total)

ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol.

Sepsis is a major cause of death among hospitalised patients. Accumulating evidence suggests that immune response during sepsis cascade lies within a spectrum of dysregulated host responses. On the on... ImmunoSep is a randomised placebo-controlled phase 2 clinical trial with a double-dummy design in which the effect of precision immunotherapy on sepsis phenotypes with MALS and immunoparalysis is stud... The protocol is approved by the German Federal Institute for Drugs and Medical Devices; the National Ethics Committee of Greece and by the National Organization for Medicines of Greece; the Central Co... NCT04990232....

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.

Baricitinib and dexamethasone have randomised trials supporting their use for the treatment of patients with COVID-19. We assessed the combination of baricitinib plus remdesivir versus dexamethasone p... In this randomised, double-blind, double placebo-controlled trial, patients were enrolled at 67 trial sites in the USA (60 sites), South Korea (two sites), Mexico (two sites), Singapore (two sites), a... Between Dec 1, 2020, and April 13, 2021, 1047 patients were assessed for eligibility. 1010 patients were enrolled and randomly assigned, 516 (51%) to baricitinib plus remdesivir plus placebo and 494 (... In hospitalised patients with COVID-19 requiring supplemental oxygen by low-flow, high-flow, or non-invasive ventilation, baricitinib plus remdesivir and dexamethasone plus remdesivir resulted in simi... National Institute of Allergy and Infectious Diseases....

Comparison Between Esketamine and Alfentanil for Hysteroscopy: A Prospective, Double-Blind, Randomized Controlled Trial.

This study aimed to establish the 95% effective dose (ED95) of esketamine in combination with propofol for hysteroscopy and then to evaluate its efficacy and safety profile.... This prospective, double-blind, randomized controlled trial consisted of two cohorts. In cohort 1, 45 women aged 18-65 years undergoing hysteroscopy were randomly assigned to either group E (esketamin... The ED95 of esketamine was 0.254 mg/kg (95% CI: 0.214-1.004), while that of alfentanil was 9.121 μg/kg (95% CI: 8.479-13.364). The anesthesia success rate was 93.0% in group E and 95.2% in group A (p ... This study determined the ED 95 dose of esketamine for intravenous general anesthesia during hysteroscopy. Esketamine showed less respiratory and hemodynamic depression, as well as fewer adverse effec... www.chictr.org.cn, (ChiCTR2300077283); registered November 3, 2023....

A Double-Blind, Randomized, Placebo-Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease.

Rescue of mitochondrial function is a promising neuroprotective strategy for Parkinson's disease (PD). Ursodeoxycholic acid (UDCA) has shown considerable promise as a mitochondrial rescue agent across... To investigate the safety and tolerability of high-dose UDCA in PD and determine midbrain target engagement.... The UP (UDCA in PD) study was a phase II, randomized, double-blind, placebo-controlled trial of UDCA (30 mg/kg daily, 2:1 randomization UDCA vs. placebo) in 30 participants with PD for 48 weeks. The p... UDCA was safe and well tolerated, and only mild transient gastrointestinal adverse events were more frequent in the UDCA treatment group. Midbrain... High-dose UDCA is safe and well tolerated in early PD. Larger trials are needed to further evaluate the disease-modifying effect of UDCA in PD. © 2023 The Authors. Movement Disorders published by Wile...

Intravenous vitamin C for vasoplegia: A double-blinded randomised clinical trial (VALENCIA trial).

To determine whether intravenous vitamin C compared with placebo, reduces vasopressor requirements in patients with vasoplegic shock.... Double-blinded, randomised clinical trial (RCT) conducted in two intensive care units in Perth, Australia. Vasopressor requirements at enrolment needed to be >10 μg/min noradrenaline after hypovolaemi... Of the 71 patients randomised (35 vitamin C, 36 placebo group), the median vasopressor duration was 44 h [95% CI, 37-54 h] and 55 h [95% CI, 33-66 h]) in the vitamin C and placebo groups (p = 0.057). ... In this RCT of patients with vasoplegic shock of at least moderate severity, the use of IV vitamin C compared with placebo did not significantly reduce the duration of vasopressors.... Prospective registration - trial number ACTRN12617001392358....

Pirfenidone in fibrotic hypersensitivity pneumonitis: a double-blind, randomised clinical trial of efficacy and safety.

Fibrotic hypersensitivity pneumonitis (FHP) is an irreversible lung disease with high morbidity and mortality. We sought to evaluate the safety and effect of pirfenidone on disease progression in such... We conducted a single-centre, randomised, double-blinded, placebo-controlled trial in adults with FHP and disease progression. Patients were assigned in a 2:1 ratio to receive either oral pirfenidone ... After randomising 40 patients, enrolment was interrupted by the COVID-19 pandemic. There was no significant between-group difference in FVC% at week 52 (mean difference -0.76%, 95% CI -6.34 to 4.82). ... The trial was underpowered to detect a difference in the primary end point. Pirfenidone was found to be safe and improved PFS in patients with FHP.... NCT02958917....

Comparison of intravenous ibuprofen and tenoxicam efficiency in ankle injury: a randomized, double-blind study.

Pain after soft tissue injuries in and around the ankle is a troublesome process in terms of patient comfort and mobilization. The aim of this study was to compare the analgesic efficacy of intravenou... We conducted a prospective, double-blind, randomized controlled study in a tertiary hospital. The patients were divided into two groups as those administered IV 400 mg ibuprofen and IV 20 mg tenoxicam... One hundred and twenty-four patients were included in the study. There were 62 patients in the tenoxicam group and 62 patients in the ibuprofen group. When VAS scores were compared, it was found that ...

The effect of synbiotic supplementation on hypothyroidism: A randomized double-blind placebo controlled clinical trial.

We hypothesize that synbiotic supplementation could modulate the intestinal microbiota and subsequently, improve the condition of hypothyroid patients.... Fifty-six adult hypothyroid patients were recruited to this double-blind, placebo-controlled, randomized clinical trial. The intervention was 10 weeks of synbiotic (500 mg of 109 CFU/g probiotics plus... Analysis on 51 patients who completed the trial showed that TSH and depression (p> 0.05) did not change significantly, while serum FT4 significantly increased in both groups (p = 0.03 and p = 0.02 in ... Ten-week supplementation with synbiotic had no favorable effect on depression and TSH, but it improved blood pressure and quality of life in patients with hypothyroidism. More trials are needed to sup... IRCT20210926052583N1, Iranian Registry of Clinical Trials (IRCT), registered October 1st, 2021....